We first determined effects of CRISPR-Cas9-mediated knockout (KO) of LSD1 on the CoREST complex and on GFI1 and its targets in AML OCI-AML5 and post-MPN sAML SET-2 cells. The gene discussed is RCOR1; the disease is acute myeloid leukemia.